Cardura (Doxazosin) Dosing for BPH
Start doxazosin at 1 mg once daily (morning or evening), then titrate at 1-2 week intervals through 2 mg, 4 mg, up to a maximum of 8 mg once daily based on symptom response and tolerability. 1
Initial Dosing and Titration
- Begin with 1 mg once daily as the FDA-approved starting dose for BPH, which can be taken either in the morning or evening 1
- Titrate upward at 1-2 week intervals to 2 mg, then 4 mg, and finally 8 mg once daily depending on the patient's urodynamic response and symptom improvement 1
- The maximum recommended dose is 8 mg once daily for BPH treatment 1
- Monitor blood pressure for at least 6 hours after the initial dose and each dose increase to detect orthostatic hypotension 1
Important Safety Considerations
- Alpha-blockers like doxazosin are strongly associated with orthostatic hypotension, especially in older adults 2
- Avoid doxazosin in patients with standing systolic blood pressure <110 mmHg or pre-existing orthostatic hypotension 2
- If therapy is discontinued for several days, restart using the initial 1 mg dosing regimen rather than resuming at the previous higher dose 1
- Measure orthostatic blood pressure by having the patient sit/lie for 5 minutes, then measure BP at 1 and 3 minutes after standing 2
Clinical Efficacy Timeline
- Significant symptom improvement typically occurs within 1 month, with further improvements continuing through 3 months of therapy 3, 4
- Mean effective doses in clinical studies were 4 mg daily for normotensive patients and 6.4 mg daily for hypertensive patients 4
- Long-term efficacy is maintained for up to 48 months with sustained improvement in urinary flow rates and symptom scores 4
Alternative Alpha-Blocker Consideration
- Tamsulosin has a significantly lower probability of orthostatic hypotension compared to doxazosin and may be preferred in elderly or frail patients at higher risk for falls 2
- Consider adding a 5-alpha reductase inhibitor (finasteride 5 mg or dutasteride 0.5 mg daily) if prostate volume is >30 cc, as combination therapy may provide additive benefits 5
Common Pitfalls to Avoid
- Do not skip the titration schedule - jumping directly to higher doses significantly increases the risk of first-dose syncope and orthostatic hypotension 1
- Do not use doxazosin as first-line in patients already at high fall risk - the 2021 AUA guidelines recommend alpha-blockers as initial therapy, but clinical judgment should prioritize patient safety in frail elderly patients 5, 2
- Do not combine with another alpha-blocker (like tamsulosin) as this dramatically increases orthostatic hypotension risk without additional BPH benefit 2
- If orthostatic hypotension develops, switch to an alternative agent (like tamsulosin or a 5-ARI) rather than simply reducing the doxazosin dose 2
Blood Pressure Effects
- In hypertensive patients, doxazosin produces clinically significant BP reductions (approximately 8/11 mmHg systolic/diastolic) 4
- In normotensive patients, BP decreases are minimal (approximately 4/2 mmHg) and generally not clinically significant 4, 6
- Doxazosin can be safely added to existing antihypertensive regimens in patients with controlled hypertension without causing excessive BP reduction 6